ESR1 and triple-negative breast carcinoma: Triple-negative breast cancer (TNBC) is defined by the absence of expression of the estrogen receptor (ERα), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), and accounts for approximately 10-15% of all breast cancers.